Emicizumab in Acquired Hemophilia A
Condition(s):Hemophilia A, AcquiredLast Updated:January 9, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Hemophilia A, AcquiredLast Updated:January 9, 2023Completed
Condition(s):Acquired HaemophiliaLast Updated:July 27, 2011Unknown status
Condition(s):Acquired HaemophiliaLast Updated:May 29, 2018Unknown status
Condition(s):Acquired Hemophilia ALast Updated:February 26, 2024Recruiting
Condition(s):Acquired Hemophilia ALast Updated:June 15, 2023Completed
Condition(s):Acquired Haemophilia; RegisterLast Updated:June 18, 2013Completed
Condition(s):Hemophilia ALast Updated:March 21, 2024Recruiting
Condition(s):Acquired Hemophilia ALast Updated:May 13, 2021Completed
Condition(s):Acquired Hemophilia ALast Updated:December 29, 2022Completed
Condition(s):Acquired Hemophilia ALast Updated:November 23, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.